Pharmaindo

Easy Read- Indonesia\’s Pharmaceutical Industry

Investment – by July 2005

Indonesia Pharmaceutical Published by Pacific Bridge Medical By Ames Gross and Rachel Weintraub July 2005 The pharmaceutical market in Indonesia is currently valued at around $350 million. More than 50 percent of the market is comprised of imported products, with a large portion coming from the U.S., Germany, Switzerland and Japan. Foreign companies importing finished products or raw materials into Indonesia are required to obtain an import license from the Ministry of Health. The National Agency of Drug and Food Control (NA-DFC) is responsible for ensuring the safety, quality and efficacy of pharmaceuticals in Indonesia. The NA-DFC also handles the drug application review process and grants drug approvals in the form of a marketing authorization license

June 27, 2006 - Posted by | Facts

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: